Justice Department, Antitrust Division
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Antitrust Division Notice is hereby given that, on October 3, 2025, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Rapid Response Partnership Vehicle (“RRPV”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Acurx Pharmaceuticals Inc., Staten Island, NY; Advanced Concept Innovations, LLC, Lakeland, FL; Altis Biosystems, Inc., Durham, NC; Amplitude Therapeutics, Inc., Boston, MA; Ananda Devices, Inc., Laval, CANADA; Arizona State University, Tempe, AZ; Arzeda Corp, Seattle, WA; Athem LLC, Morrisville, NC; Avocet Bio GmbH, Goettingen, FEDERAL REPUBLIC OF GERMANY; Baebies, Inc., Durham, NC; Barupon L.L.C., Irvine, CA; Beckman Research Institute of the City of Hope, Duarte, CA; Bethyl Laboratories, Inc., Montgomery, TX; BioStrategies LC, Jonesboro, AR; Biopico Systems INC, Irvine, CA; Biosynchronicity Corporation, Bellevue, WA; Blueprint Biosecurity, Washington, DC; CURA Diagnostics, Inc., Woburn, MA; Caci, Inc.—Federal, Chantilly, VA; Cfd Research Corporation, Huntsville, AL; Chembio Diagnostic Systems Inc., Medford, NY; Curavit Clinical Research Corp, Scarsdale, NY; Curi …
Citation: 91 FR 8529
